SBG

In Situ Polymerizing Peripheral Nerve Cap

Product code
SBG
Device name
In Situ Polymerizing Peripheral Nerve Cap
Device class
Class 2
21 CFR
21 CFR 882.5260
Medical specialty
Neurology
Marketing pathway
510(K)
Flag
Implant
510(k) clearances (last 3 years)
2

FDA classification definition

An in situ polymerizing peripheral nerve cap is a prescription use only device composed of precursor materials that polymerize when delivered to the end of a peripheral nerve to function as a physical barrier to the surrounding in vivo environment to reduce the risk of formation of a symptomatic neuroma.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2025-09-29.

NumberDecision dateApplicantDevice nameSummary
K2520512025-09-29Tulavi Therapeutics, Inc.allay Nerve Cap (TL5515-1); allay Nerve Cap (TL551PDF
DEN2300612024-07-16Tulavi Therapeuticsallay Nerve Cap

1 summaries are archived here for direct download.

Official FDA classification page: SBG
Classification and pathway per current FDA publications. Data from openFDA (CC0).